AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer patients Read more
Aleor Dermaceuticals receives US FDA final approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% Read more